Dr. Reddy’s launches drug-free migraine management device Nerivio in Europe following successful launch in India
Dr. Reddy’s Laboratories Ltd a global pharmaceutical company, announced the launch of the drug-free non-invasive migraine management wearable device Nerivio® in Germany through its step-down subsidiary betapharm. The launch marks the company’s entry into digital therapeutics in Europe. Nerivio® is approved by the United States Food and Drug Administration (USFDA), and is CE-mark certified in Europe.